ID GENOMICS SPC
Seattle, WA · Founded 2012 · CIK 0001665654 · Medtech · Private
Rapid PCR-based diagnostic test for detection and genetic fingerprinting of SARS-CoV-2 variants using nested multiplex reverse transcription PCR with lateral flow readout
idgenomics.com →- Grants
- $4.5M
- 3 awards
- Sector median: 1
- Raised
- $110K
- 2 Form D · Mar 2018
- 103 months since last filing
- Contracts
- $4K
- 1 award · Agriculture
- #639 of 4531 in medtech
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20152016201720182019202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · Clonotyping Technology for Prediction of Antibiotic Resistance | $2,953,422 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Clonotyping Technology for Prediction of Antibiotic Resistance | $1,214,403 | |
| Private capital raised | Form D · SEC | $50,000 | |
| Private capital raised | Form D · SEC | $60,000 | |
| Federal contract | Department of Agriculture · Matagenomics For Worm Castings | $4,150 | |
| Federal grant | Department of Health and Human Services · Phase I · Rapid Genetic Fingerprinting of SARS-Cov-2 Variants | $299,200 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 636 | Biofrontera Inc. | $6K | $58M |
| 637 | TRICOL BIOMEDICAL, INC | $6K | — |
| 638 | Earlens Corp | $5K | $260M |
| 639 | ID GENOMICS SPC | $4K | $110K |
| 640 | Sofregen Medical Inc. | $4K | $14M |
| 641 | Core Essence Orthopaedics, Inc. | $4K | $7.1M |
| 642 | GENOMICS USA, INC. | $3K | $837K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Glenn KawasakiDirector · Executive Officer · Promoter
- Jeffrey OsterDirector · Executive Officer · Promoter
- Kaveri ParkerDirector · Executive Officer · Promoter
- Mansour SamadpourDirector
- Evgueni SokourenkoDirector · Executive Officer · Promoter
- Evgeni SokurenkoDirector · Executive Officer · Promoter
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.